Advice
in the absence of a submission from the holder of the marketing authorisation:
remimazolam (Byfavo®) is not recommended for use within NHSScotland.
Indication under review: in adults for intravenous induction and maintenance of general anaesthesia.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result, we cannot recommend its use within NHSScotland.
Download detailed advice237KB (PDF)
Medicine details
- Medicine name:
- remimazolam (Byfavo)
- SMC ID:
- SMC2692
- Indication:
In adults for intravenous induction and maintenance of general anaesthesia.
- Pharmaceutical company
- Paion UK Limited
- BNF chapter
- Anaesthesia
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 July 2024